RVMD – revolution medicines, inc. (US:NASDAQ)
Stock Stats
News
12/4
05:57 am
rvmd
Low
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. [Business Insider]
11/20
06:02 am
rvmd
Low
Revolution Medicines (NASDAQ:RVMD) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
11/18
09:00 am
rvmd
Low
Revolution Medicines (NASDAQ:RVMD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $75.00 price target on the stock.
11/17
12:14 pm
rvmd
Low
Hot Picks: Cancer-focused biotech firms gain attention as key clinical results near [BNN Bloomberg (Canada)]
11/11
10:58 am
rvmd
Low
Revolution Medicines, Inc. (RVMD) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
11/5/2025
04:02 pm
RVMD
3.4%
MISS
8/6/2025
04:02 pm
RVMD
-4.7%
MISS
5/7/2025
04:02 pm
RVMD
11.3%
MISS
2/26/2025
04:02 pm
RVMD
-3.5%
MISS
11/20
06:02 am
Upgrades
Strong-Buy
Wolfe Research
Low
-1.9%
11/20
06:02 am
Upgrades
Strong-Buy
Wolfe Research
Low
-1.9%
11/18
11:43 am
Initiates
Outperform
Wolfe Research
Low
1.8%
11/18
11:43 am
Initiates
Outperform
Wolfe Research
Low
1.8%
11/18
09:00 am
Initiates
Outperform
Wolfe Research
Low
1.9%
11/26
04:16 pm
rvmd
Low
Form 4 Revolution Medicines, For: Nov 25 Filed by: Anders Jack
11/26
04:16 pm
rvmd
Low
Form 4 Revolution Medicines, For: Nov 25 Filed by: GOLDSMITH MARK A
11/25
04:29 pm
rvmd
Low
Form 144 Revolution Medicines, Filed by: GOLDSMITH MARK A
11/25
04:29 pm
rvmd
Low
Form 144 Revolution Medicines, Filed by: GOLDSMITH MARK A
11/25
04:29 pm
rvmd
Low
Form 144 Revolution Medicines, Filed by: GOLDSMITH MARK A
Show more
Top News Gainers
4/29 Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models 8.7%
3/18 Form SEC STAFF LETTER Revolution Medicines, 7.6%
4/16 Bill.com Holdings (NASDAQ: RVMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $27.00 price target on the stock. 6.6%
2/24 Form SC 13G Revolution Medicines, Filed by: Cormorant Asset Management, LP 4.5%
2/14 Form 4 Revolution Medicines, For: Feb 12 Filed by: Kelsey Stephen Michael 3.8%
2/18 Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares 3.3%
3/20 Form 8-K Revolution Medicines, For: Mar 18 3.1%
4/21 Form 8-K Revolution Medicines, For: Apr 17 2.6%
2/12 Form 3 Revolution Medicines, For: Feb 12 Filed by: GOEDDEL DAVID V 2.4%
4/17 Bill.com Holdings (NASDAQ: RVMD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 1.7%
Top News Decliners
3/12 Form SEC STAFF LETTER Revolution Medicines, -17.9%
5/1 Bill.com Holdings (NASDAQ: RVMD) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $38.00 price target on the stock. -5.7%
2/20 Form 4 Revolution Medicines, For: Feb 18 Filed by: Exter Neil -3.9%
2/14 Form SC 13G/A Revolution Medicines, Filed by: Boxer Capital, LLC -2.3%
3/30 Form 10-K Revolution Medicines, For: Dec 31 -1.9%
3/18 Revolution Medicines Announces Issuance of U.S. Patent Covering Compositions of Matter for its Clinical-Stage SHP2 Inhibitor Program -1.6%
2/19 Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs [Yahoo! Finance News] -0.9%
3/9 New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute -0.4%
2/13 Form SC 13G Revolution Medicines, Filed by: Boxer Capital, LLC -0.3%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3